Tag

Insulin Resistance

All articles tagged with #insulin resistance

PMOS: A new name for PCOS aims to improve diagnosis and care
health10 days ago

PMOS: A new name for PCOS aims to improve diagnosis and care

Experts rename polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its broader hormonal and metabolic features, not just ovarian cysts; diagnosis centers on irregular periods and signs of high androgens, with infertility and pregnancy risks acknowledged. Treatment emphasizes lifestyle changes and individualized options such as metformin, anti-androgens, and hormonal birth control based on fertility goals.

PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots
health10 days ago

PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots

PMOS, the official rename of PCOS (polycystic ovarian syndrome), reframes the condition as a multisystem endocrine and metabolic disorder driven largely by insulin resistance, not just ovarian cysts. The Lancet consensus (May 12, 2026) involved about 22,000 experts and 56 organizations to improve diagnosis, reduce stigma, and guide treatment toward metabolic health and personalized care. Diagnosis now emphasizes signs of androgen excess, menstrual history, and metabolic testing, with management focusing on lifestyle changes, glucose control, and targeted therapies, while fertility considerations are addressed when relevant. It is lifelong but manageable with proper care and advocacy.

PCOS Gets a Fresh Identity: PMOS Aims to Reflect Multisystem Roots
health16 days ago

PCOS Gets a Fresh Identity: PMOS Aims to Reflect Multisystem Roots

A global health consortium renames polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better capture its multisystem nature, remove the misleading focus on ovaries, and reduce stigma. After 14 years of collaboration, the group plans to push PMOS into ICD classifications within three years and raise public and professional awareness. The condition affects about 170 million people worldwide, with up to 70% undiagnosed, and often involves metabolic, endocrine, psychological, and dermatological symptoms beyond reproduction. The renaming emphasizes insulin resistance and diabetes risk, potentially guiding research, screening, and treatment, including the continued, and sometimes off-label, use of drugs like metformin. The Lancet policy paper outlines the strategy to educate globally and secure official ICD updates.

Even 'Healthy' Drinks Can Damage Your Liver, Hepatologists Warn
health1 month ago

Even 'Healthy' Drinks Can Damage Your Liver, Hepatologists Warn

Hepatologists warn that the liver can be damaged not only by alcohol but also by everyday drinks—especially fruit juice—because MASLD (metabolic dysfunction-associated steatotic liver disease) can develop from metabolic syndrome. Excessive fruit juice can cause weight gain and insulin resistance, leading to fat buildup in the liver; fiber and whole fruit help protect the liver. Limit fruit juice, read sugar content, and consult a clinician or dietitian to tailor intake.

Juice Isn’t a No-Calories Elixir: Big Study Links 100% Fruit Juice to Weight Gain
health2 months ago

Juice Isn’t a No-Calories Elixir: Big Study Links 100% Fruit Juice to Weight Gain

A large meta-analysis published in JAMA Pediatrics found that each additional daily serving of 100% fruit juice is linked to weight gain in both children and adults (about a 0.03 BMI increase per serving in kids and 0.02 in adults). Experts say this may be due to extra calories and rapidly digested sugars from juice, plus the fiber lost when juicing. The takeaway is to prioritize whole fruit, choose 100% juice with no added sugars, limit juice to roughly 4–6 ounces if you drink it, and consider diluting with sparkling water to keep portions small while still enjoying the beverage.

Seven hours of sleep linked to lower diabetes risk, study finds
health2 months ago

Seven hours of sleep linked to lower diabetes risk, study finds

A large observational study of about 25,000 people (2009–2023) found that roughly seven hours and 18 minutes of nightly sleep was associated with the lowest insulin resistance, while both shorter and longer sleep linked to worse metabolic markers; weekend catch-up sleep did not offset deficits, and self-reported data limit causal conclusions. Experts say sleep is important for metabolic health but not a standalone solution, with guidance generally suggesting about 7–9 hours of regular, high‑quality sleep to help reduce diabetes risk.

Smartwatch data plus routine labs power scalable insulin-resistance screening
healthcare2 months ago

Smartwatch data plus routine labs power scalable insulin-resistance screening

The WEAR-ME study (n=1,165) shows that combining wearable time-series data with demographics and routine blood biomarkers can predict insulin resistance (HOMA-IR ≥2.9) with AUROC around 0.80. Using a wearable foundation model to derive richer representations further improves performance, achieving AUROC ~0.82 in cross-validation, and up to ~0.88 when fasting glucose and a lipid/metabolic panel are included. An independent validation cohort confirms gains with wearable data, and an LLM-based insulin-resistance literacy agent is demonstrated to contextualize results and provide personalized guidance. The work proposes a scalable, noninvasive screening approach to identify at-risk individuals for early lifestyle interventions to prevent type 2 diabetes, while noting limitations in data missingness, generalizability, and the need for longitudinal validation.

Around 7.3 Hours of Sleep May Minimize Insulin Resistance, Study Suggests
health2 months ago

Around 7.3 Hours of Sleep May Minimize Insulin Resistance, Study Suggests

A cross‑sectional NHANES analysis found that about 7.32 hours of weekday sleep is linked to the best estimated glucose disposal rate (eGDR), a marker of insulin sensitivity; sleeping more beyond this threshold is associated with lower eGDR. Weekend catch‑up sleep helped those who slept less than 7.32 hours but may worsen insulin resistance if it exceeds two hours, with stronger effects in women, middle‑aged adults, and those with BMI ≥30. The study cannot prove causation and relies on self‑reported sleep, so results should be interpreted cautiously. The takeaway is to aim for consistent 7–8 hours per night and moderate weekend catch‑up if needed.

Unlocking the Diabetes Sleep Window: 7 Hours 19 Minutes
health2 months ago

Unlocking the Diabetes Sleep Window: 7 Hours 19 Minutes

A study of more than 10,000 adults links a nightly sleep of 7.32 hours (7 hours 19 minutes) with lower insulin resistance and diabetes risk. Sleeping significantly less or more than this duration may raise risk, with effects varying by sex and age. Weekend catch-up sleep helps only for those with weekday sleep debt (about 1–2 hours); for others, extra weekend sleep can worsen risk. Findings support personalized sleep guidance as a key part of diabetes prevention.

Budget-Friendly Metformin Cuts Insulin Dose in Type 1 Diabetes, Trial Shows
health2 months ago

Budget-Friendly Metformin Cuts Insulin Dose in Type 1 Diabetes, Trial Shows

A 26-week randomized trial (INTIMET) in 40 adults with long-standing type 1 diabetes found metformin did not improve insulin resistance or glucose control, but reduced total daily insulin requirements by about 12% compared with placebo, suggesting metformin may ease the insulin burden rather than reverse insulin resistance; researchers are exploring whether gut microbiome interactions explain the effect.

Vitamin D May Slow Diabetes Risk in Prediabetes
health3 months ago

Vitamin D May Slow Diabetes Risk in Prediabetes

A meta‑analysis of about 4,500 people with prediabetes across 10 trials found vitamin D supplementation modestly increased the share who reached normal blood sugar (18.5% vs 14% on placebo), suggesting potential improvements in glycemic control and insulin resistance, though effects vary and aren’t guaranteed. Experts say vitamin D should complement—not replace—lifestyle changes (low‑glycemic diet, weight management, regular exercise) and medical guidance; typical study doses were around 4,000 IU daily, with precautions against toxicity and the need to check vitamin D levels with a clinician.

Metabolic Health Demystified: Why Weight and Inflammation Drive Long-Term Risk
health4 months ago

Metabolic Health Demystified: Why Weight and Inflammation Drive Long-Term Risk

Metabolic health hinges on avoiding metabolic syndrome, defined by at least three of: central obesity, high triglycerides, low HDL, high blood pressure, and high blood sugar. With roughly three-quarters of US adults being overweight or obese, excess fat—especially visceral fat—drives inflammation and insulin resistance, elevating risk for heart disease, kidney disease, diabetes, MASLD, and some cancers. Prevention focuses on weight loss and lifestyle changes (quit smoking, more exercise, heart-healthy diets like Mediterranean/DASH, adequate sleep). If needed, GLP-1 medications can reverse obesity and reduce downstream risks. Early warning signs such as rising blood pressure or glucose should prompt medical advice to halt progression.